From #ESCCongress2025 - Prof. Christi Deaton explains why the ESC consensus statement on #MentalHealth and #CVD is needed and outlines the key recommendations.

Watch the full interview here 👉 buff.ly/vZQrLyq

#CardioSky

Watch Gregory Piazza and Rohan Wijesurendra share their key takeaways from this year’s #ESCCongress, focusing on navigating bleeding risk in patients with provoked VTE and the future of asymptomatic AF screening and diagnosis #MedSky #CardioSky #ESCCongress2025 #WCCardio

ow.ly/snbI50X5G6T

ESC Congress 2025. Oxford University Press online booklist. Get 40% off books.

The science doesn’t stop when the ESC Congress ends!

You can explore expert insights, Guidelines, and key takeaways from #ESCCongress2025 on our dedicated Congress Hub page: oxford.ly/4mw87Sg

@escardio.bsky.social

From #ESCCongress2025 - Prof. Milind Desai takes us through the key findings of the ODYSSEY-HCM study of #mavacamten in people with symptomatic nonobstructive hypertrophic #cardiomyopathy.

Watch the full interview here 👉 buff.ly/An0NdBI

#CardioSky

Can ICDs improve survival in post-MI patients with mildly impaired LVEF? @mmamas1973.bsky.social and Derek Exner discuss this topic during the recent #ESCCongress2025. www.tctmd.com/videos/beyon...

At #ESCCongress2025, @mmamas1973.bsky.social and Raffaele Piccolo talk about the PARTHENOPE trial that tested a new polymer-free drug-eluting stent. www.tctmd.com/videos/beyon...

In this Beyond the Data, @mmamas1973.bsky.social, Giuseppe Tarantini, and Pedro Lemos discuss two new trials that were presented at #ESCCongress2025 which looked at anticoagulation strategies in post-ACS patients. www.tctmd.com/videos/beyon...

Dive into OUP's ESC Congress 2025 Hub to learn more.

From heart failure to AI in cardiology, the #ESCCongress2025 covered it all!

Dive into our ESC Congress 2025 Hub to learn more: oxford.ly/4pLLagT

@escardio.bsky.social

Lift as You Rise: Women in Cardiology Meet in Madrid to Talk Change The RISE @ ESC Congress 2025 meeting made clear that policies matter, but so too do interpersonal connections on a local scale.

The second annual RISE conference at #ESCCongress2025, organized by @womenasone.bsky.social, highlighted the need to continue elevating women pursuing careers in medicine and clearing professional barriers from sexism to lack of equitable care for female patients. www.tctmd.com/news/lift-yo...

Visit ESC Congress 2025 Hub page today.

Catch up on ESC Hotlines and simultaneous publications from #ESCCongress2025!

The ESC Congress Hub brings you the latest research, editor picks, and journal news - all in one place. 🔗 oxford.ly/3JWMD3d

@escardio.bsky.social #ESCJournals

What's the link between inflammation and CVD? Caitlin E. Cox, Jean-Claude Tardif, and Charalambos Antoniades discuss this and more at #ESCCongress2025 in the latest On Record. www.tctmd.com/videos/on-re...

AMALFI: Modest AF Detection With ECG Patch Screening Whether such screening reduces the risk of stroke and other hard clinical endpoints remains to be seen, say investigators.

Using a noninvasive ECG patch modestly increases the detection of AF and treatment with anticoagulant therapy among patients at moderate-to-high risk for stroke, based on results from the AMALFI trial presented at #ESCCongress2025. www.tctmd.com/news/amalfi-...

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD What to make of the registry findings is debatable, but a mortality signal in PAD patients with claudication raised eyebrows.

More questions are raised over the safety of paclitaxel-coated devices in PAD, according to the SWEDEPAD 1 and 2 national registry trials presented at #ESCCongress2025. Read the full story here: www.tctmd.com/news/renewed...

Personalized DAPT beats standard approach for ischemic–bleeding risk balance Personalizing dual antiplatelet therapy duration after PCI offers greater clinical benefit than the standard 12-month strategy for balancing ischemic and bleeding risks, according to the PARTHENOPE…

From #ESCCongress2025 - Personalizing #DAPT duration after PCI offers greater clinical benefit than the standard 12-month strategy for balancing ischemic and bleeding risks, according to the PARTHENOPE trial.

👉 buff.ly/SAAbynK

#MedNews #CardioSky

In Beyond the Data, @mmamas1973.bsky.social and Robert Giugliano talk about the data on starting an SGLT2 inhibitor in patients hospitalized with acute heart failure during #ESCCongress2025. www.tctmd.com/videos/beyon...

Is biologic inflammation predictive of CVD? At #ESCCongress2025, Caitlin E. Cox and Paul Ridker discuss the research behind the inflammatory hypothesis and its implications for clinical practice. www.tctmd.com/videos/on-re...

The latest Beyond the Data has @mmamas1973.bsky.social, Dan Atar, and Borja Ibáñez discussing data from the REBOOT-CNIC and BETAMI-DANBLOCK trials at #ESCCongress2025. Watch the full video now: www.tctmd.com/videos/beyon...

Lift as You Rise: Women in Cardiology Meet in Madrid to Talk Change The RISE @ ESC Congress 2025 meeting made clear that policies matter, but so too do interpersonal connections on a local scale.

www.tctmd.com/news/lift-yo... #CardioSky #ESCCongress2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients A focused update to the dyslipidemia guidelines makes room for new drugs, statins in HIV, and early combo therapy for some.

www.tctmd.com/news/esceas-... #CardioSky #ESCCongress2025

ESC/EACTS Release New Valvular Heart Disease Guidelines Among the changes are a lower TAVI age cutoff and greater emphasis on patient education and coronary CTA.

The ESC/EACTS have released new valvular heart disease guidelines at #ESCCongress2025, which lower the age cutoff to recommend TAVI over SAVR and more strongly emphasize patient education, according to ESC chairperson Fabien Praz and EACTS chairperson Michael Borger. www.tctmd.com/news/esceact...

Why mental health should be included in cardiovascular care A new Clinical Consensus Statement from the European Society of Cardiology (ESC) is calling for greater awareness of the multidirectional relationship between mental health conditions and cardiovascul...

Systematic #screening and support for #mentalhealth conditions such as #depression, #anxiety, or #PTSD should become normalised in #cardiovascular care, cardiologists led by 🇪🇸 CNIC and 🇬🇧 @cam.ac.uk urge in a new Consensus Statement published at the @escardio.bsky.social #ESCCongress2025.

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD In addition to less restrictive guidance for some high-risk patients, the document advises vaginal birth whenever possible.

www.tctmd.com/news/esc-gui... #CardioSky #ObSky #ESCCongress2025

At the recent #ESCCongress2025, @mmamas1973.bsky.social, Dan Atar, and Borja Ibáñez discuss data from the REBOOT-CNIC and BETAMI-DANBLOCK trials, which looked at beta-blockers in post-MI patients without heart failure or impaired LVEF. www.tctmd.com/videos/beyon...

ICD No Help for High-Risk, Post-MI Patients With Moderately Reduced EF The REFINE-ICD results highlight the need to find better ways to identify at-risk patients who might benefit, one expert says.

High-risk post-MI patients with moderately reduced EF don't see improved outcomes with an ICD, based on results from the REFINE-ICD trial reported at #ESCCongress2025. Read more here: www.tctmd.com/news/icd-no-...

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC The “antithrombotic sweet spot” means continuing with oral anticoagulation alone in the chronic phase, Renato Lopes says.

Using aspirin with OAC more than 6 months after PCI can be harmful to patients, according to the AQUATIC trial reported at #ESCCongress2025. Compared with OAC alone, adding aspirin leads to worse clinical outcomes, a higher risk of CV death, and increased major bleeding www.tctmd.com/news/aquatic...

NATURE-Legacy study compares MR/genetically modeled life long LDL-C and blood pressure lowering (HR 0.32) to short term effects in the HOPE-3 trial (HR 0.71). By Brian Ference, et al. /1 #ESCCongress2025 #cardiosky

#Madrid #Spain #cardiovascular #hearthhealth #ESCCongress2025 #ESC

Today is the final day of #ESCCongress2025! Catch up on all the coverage from this year's conference in Madrid by visiting the TCTMD website. www.tctmd.com/conference/e...

Boosting Potassium Helps Patients at High Risk for Ventricular Arrhythmias (UPDATED) Patients with advanced heart failure, who are already followed closely, might be a good population to focus on, one expert says.

Increasing low potassium levels improves clinical outcomes among patients with CVD and a high risk for ventricular arrhythmias, according to results from the POTCAST trial reported at #ESCCongress2025. www.tctmd.com/news/boostin...

Glasgow soaking up science in Madrid! #ESCCongress2025 #academicLife #publicHealth #cardiovascularLife @uofgscmh.bsky.social @uofgshw.bsky.social